Petros Pharmaceuticals, Inc. (PTPI) vs China SXT Pharmaceuticals, Inc. (SXTC)

Petros Pharmaceuticals, Inc. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Petros Pharmaceuticals, Inc. is the larger, with a market value of $1.0M against $710.0K — 1.5× the size. Petros Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 36.1% against −54.0%. Petros Pharmaceuticals, Inc. has the higher net margin (0.00% vs −255.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Petros Pharmaceuticals, Inc. leads on 8 and China SXT Pharmaceuticals, Inc. on 4.

Valuation

Metric PTPI SXTC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S n/m n/m 2.11
P/B n/m n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 2.66 12.58
EV/Sales 0.40 (5.94) 2.73
Earnings yield 0.00% (159,014.29%) (4.38%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric PTPI SXTC Drug Manufacturers Specialty & Generic median
Gross margin 76.35% 36.69% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (255.16%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (710.28%) 0.00% (0.40%)
Return on assets (334.15%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PTPI SXTC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 36.07% (53.98%) 10.01%
EPS growth (last fiscal year) 98.13% 97.36% 49.06%
Revenue growth, 5-year CAGR (19.98%) (24.94%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTPI SXTC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.03 0.05
Current ratio 1.25 7.94 2.31
Net debt to EBITDA 1.11 3.86 0.97

Dividend

Metric PTPI SXTC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric PTPI SXTC Drug Manufacturers Specialty & Generic median
Market cap 1.04m 710.00k 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack